Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Rush Enterprises Class A
RUSHA
$6.21B
| $10.3M | 0.02% |
246,149
-41,165
| -14% | -$1.89M |
|
902
Healthcare Realty
HR
$7.46B
| $10.3M | 0.02% |
+625,272
| New | +$9.57M |
|
903
Comfort Systems
FIX
$59.8B
| $10.3M | 0.02% |
33,800
+11,800
| +54% | +$3.75M |
|
|
PBPB
904
DELISTED
Potbelly
PBPB
| $10.3M | 0.02% |
1,278,854
-105,594
| -8% | -$978K |
|
905
The RMR Group
RMR
$333M
| $10.3M | 0.02% |
454,217
+1,303
| +0.3% | +$30.5K |
|
906
Immunovant
IMVT
$8.11B
| $10.2M | 0.02% |
388,100
+48,400
| +14% | +$1.38M |
|
907
Invesco
IVZ
$13B
| $10.2M | 0.02% |
682,200
-214,900
| -24% | -$3.3M |
|
908
Moderna
MRNA
$23B
| $10.2M | 0.02% |
85,900
-21,900
| -20% | -$2.77M |
|
|
BAND
909
Bandwidth Inc
BAND
$1.25B
| $10.2M | 0.02% |
604,200
+51,542
| +9% | +$973K |
|
|
NWLI
910
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $10.2M | 0.02% |
20,500
+4,318
| +27% | +$2.12M |
|
911
Dole
DOLE
$1.36B
| $10.2M | 0.02% |
830,900
+88,900
| +12% | +$1.08M |
|
|
FFNW
912
DELISTED
First Financial Northwest, Inc
FFNW
| $10.2M | 0.02% |
481,101
-1,000
| -0.2% | -$20.8K |
|
913
Check Point Software Technologies
CHKP
$13.1B
| $10.2M | 0.02% |
61,608
-105,700
| -63% | -$16.5M |
|
914
Matador Resources
MTDR
$6B
| $10.2M | 0.02% |
+170,506
| New | +$10.7M |
|
|
UHT
915
Universal Health Realty Income Trust
UHT
$608M
| $10.1M | 0.02% |
258,810
-2,200
| -0.8% | -$80.4K |
|
916
RCM Technologies
RCMT
$202M
| $10.1M | 0.02% |
539,373
-15,400
| -3% | -$306K |
|
917
Columbia Financial
CLBK
$1.14B
| $10.1M | 0.02% |
674,332
-15,900
| -2% | -$247K |
|
918
Boston Properties
BXP
$11.4B
| $10.1M | 0.02% |
163,900
+110,700
| +208% | +$6.76M |
|
|
AXON
919
Axon Enterprise
AXON
$42.3B
| $10.1M | 0.02% |
34,252
-5,306
| -13% | -$1.58M |
|
920
Idexx Laboratories
IDXX
$44.1B
| $10M | 0.02% |
20,604
-13,200
| -39% | -$6.63M |
|
921
Omega Healthcare
OHI
$15B
| $10M | 0.02% |
293,078
+24,400
| +9% | +$769K |
|
|
DFSD
922
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.09B
| $10M | 0.02% |
213,517
+78,838
| +59% | +$3.7M |
|
923
ATI
ATI
$24.8B
| $9.99M | 0.02% |
180,192
+44,600
| +33% | +$2.5M |
|
924
Tapestry
TPR
$30.8B
| $9.99M | 0.02% |
233,500
-239,500
| -51% | -$10M |
|
925
ANI Pharmaceuticals
ANIP
$1.83B
| $9.99M | 0.02% |
156,802
+20,900
| +15% | +$1.36M |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.